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Aim. Staphylococcus aureus (S. aureus) is a nosoco­
mial and community acquired pathogen. S. aureus is 
a pathogen that causes several types of disease from 
skin infections to systemic diseases that is because 
of having several virulence factors such as enzymes,
toxins, superantigens and Panton-Valentine leukoci­
din (pvl). pvl is a bi-component leukotoxin that de­
stroy PMNs and monocytes and causes furunculosis,
abscesses and necrotizing soft tissue infections in pa­
tients without any risk factors for such infections.The 
goal of this study was determine the prevalence of pvl
gene in S. aureus isolated from patients and healthy 
carriers in Gorgan city, north of Iran.
Methods. One hundred seventy isolates of S. aureus, 
95 from patients and 75 healthy carriers, were collect­
ed during one year. After identification and purifica­
tion, DNA extraction was done by phenol-chloroform 
method. Amplification of pvl gene was done by spe­
cific primer and polymerase chain reaction method.
Results.Among the 170 isolates of S. aureus, 20% con­
tained pvl gene. The frequency of isolates contained 
pvl gene in MRSA and MSSA isolates were 21.6%,
19.3% , which was not statistically significant.The fre­
quency of these genes was not related to age, sex and 
source of isolation from patients.
Conclusion. The frequency of pvl gene in this region 
were much higher than expected. 
Key words: Staphylococcus aureus - Panton-Valentine leu­
kocidin - Polymerase chain reaction. 
Staphylococcus aureus (S. aureus) is a nosocomial and community acquired pathogen.1  
S. aureus is a pathogen that causes several types 
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of disease from skin infections to systemic dis­
eases that is because of having several virulence
factors such as enzymes, toxins , superantigens
and Panton-Valentine leukocidin (pvl).2 pvl is a bi-
component leukotoxin that encode by lukS-PV and
lukF-PV genes and transfer from temperate bacte­
riophages.3 
pvl destroy PMNs and monocytes and causes
furunculosis , abscesses and necrotizing soft tis­
sue infections in patients without any risk factors
for such infections 4 on the other hand pvl strain
(meticillin-resistant or sensitive organisms) may be
cause Purpura fulminans with a mortality of up
to 60%.4 
The goal of this study was determine the preva­
lence of pvl gene in S. aureus isolated from patients 
and healthy carriers in Gorgan city, north of Iran.
Materials and methods 
Bacterial isolates 
In this research we studied on 170 isolate of S. au­
reus (95 from patients and 75 healthy carriers) were 
collected during one year. Purification and confirm 
the diagnosis of S. aureus by biochemical tests were 
carried out as previously mentioned.5-7 
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KAMAREHEI PREVALENCE OF PANTON-VALENTINE GENE 
Figure 1.—Detection of the pvl gene by PCR (lanes 3-6,8,10). Lane 1,
-molecular weight marker; lanes 1 control  and 2 control +. 
DNA extraction 
DNA was extracted using phenol-chloroform method that 
used lyzozyme, sarcosyl, proteinase K, RNAse, phenol and 
chloroform without using lysostaphin and boiling.8 The 
purified DNA was assessed by electrophoresis and stored at 
-20 °C. 
pvl gene detection 
Polymerase chain reaction was carried out for all
the isolates (Eppendorf Thermocycler, Hamburg,
Germany) for the pvl gene in a final volume of 50 μl,
in which a standard strain USA300 was used as a pos­
itive control for pvl gene detection and distilled water
was used as negative control. The primer sequenc­
es for the pvl genes were as follows: for luk-PV-1,
5´-TCATTAGGTAAAATGTCTGGACATGATCCA-3´ for 
luk-PV-2, 5´-GCATCAASTGTATTGGATAGCAAAAGC-3´.9 
PCR matrix was containing 1 U of Taq poly­
merase(GENET BIO), 5 μL of the DNA template, 4 
μL MgCl2(GENET BIO), 1 μL of dNTP(GENET BIO) 
and 1 μL of each primer. DNA isolates were dena­
tured for 5 minutes at 94 °C, followed by 30 cycles of 
denaturing performed for 30 seconds at 94 °C, with 
annealing at 56 °C for 30 seconds, and extension 
at 72 °C for 60 seconds. Finally, 5 minutes of final 
extension were performed at 72 °C. PCR products 
were analyzed by electrophoresis through a 1.5% 
agarose gel with ethidium bromide.
Table I.—Characteristics of patients and healthy carriers of 
Staphylococcus aureus pvl -producing gene 
Property number of isolates number (%) of isolates pvl gene P-value
 Age group
 — <20 40 10 (25%) 0.6
 — 20-45 85 16 (18.8%)
 — >45 45 8 (17.8%)

    Sex

 — Man 83 13 (15.7%) 0.1
 — Woman 87 21 (24.1%) 

Type of infection

 — Urine 29 8 (27.6%) 0.2
 — Wound 23 7 (30.4%) 
— Blood 22 3 (13.6%)
 — Others 21 2 (9.5%)
 — Healthy 75 14 (18.7%) 0.4
 — Carrier 
— Patient 95 20 (21.1%)

 Methicillin resistance

 — MRSA 51 11 (21.6%) 0.4
 — MSSA 11 23 (19.3%) 
Methicillin susceptibility testing 
Susceptibility to methicillin was determined by 
the agar disc diffusion method using Muller Hin­
ton agar medium containing 2% NaCl, oxacillin disc 
(MAST Diagnostics, Merseyside, UK). All plates were 
incubated at 35 °C overnight. Molecular detection of 
this gene was performed.6 
Statistical analysis 
The data entered in SPSS ver 16 and c2 test were 
used for statistical analysis. A P-value of less than 
0.05 was considered to be statistically significant. 
Results 
Among the 170 S. aureus isolates, 34(20%) cases 
were carry pvl gene. The distribution of these isolate 
among person with age less than 20 years (25%) and 
patients (21.1%) was higher than other groups. The 
frequency pvl gene among MRSA isolates (21.6%) 
was more than MSSA, but there was not any signifi­
cant difference between them (P>0.05). 
Discussion 
Pvl strain is associated with skin and soft tissue in­
fections such as furuncles and abscesses, subcutane-
MINERVA BIOTECNOLOGICA March 2015 52
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PREVALENCE OF PANTON-VALENTINE GENE KAMAREHEI 
ous tissue and also necrotic suppurative lesions,9 It 
has also been isolated from necrotizing pneumonia 
patients without known risk factors that are neces­
sary for such infection (community-acquired S. au­
reus).10 
On the other hand, an association between pvl
strain and severity has been reported in lung and 
bone infection. Although, this is not important for 
skin and soft tissue infection; but the site of infec­
tion may be has an important role in infections that 
causes by pvl strain.11 
Our study demonstrated that the frequency of pvl
isolates were 20%. This prevalence is similar to some 
other studies performed in various region in Iran 
such as Tehran 7, 12 as well as some of countries like 
Spanish, Nigeria and Detroit.13-15 It is interesting to 
note that the prevalence of pvl in this study were 
higher than other studies in neighbor country 16-18 
and lower than African 19, 20 and American coun­
tries.21-23 
Different epidemiological factors such as type of 
strain (USA300), resistance to methicillin, CA-MRSA 
(community-associated MRSA) or HA-MRSA (hospi­
tal-associated MRSA), condition of patient and type 
of infectious have role in variability of prevalence 
of pvl. 
In this study most pvl-positive isolates were ob­
served in wound (30.4%) specimens confirming 
some of the results.12, 24, 25 Also, 27.6% of urine spec­
imens were pvl positive that could have a participat­
ing role in virulence, therefore, we suggest to survey 
gene expression. 
It is noteworthy that, pvl gene has been detected 
in MRSA strains more than MSSA strain confirming 
the observations of other studies.20, 24, 26 
Conclusions 
In conclusion, pvl was much frequent in strains 
isolated from patients, women, age group less than 
20, than in strains isolated from carriers, men and 
other age groups, but there was no evident rela­
tionship between this gene and other characteristics,
statistically (P-value >0.05). 
Finally, we suggest detection of type strain of this 
region for monitoring and control of this organism to 
reduce distribution of staphylococcal infections and 
also determine gene expression in clinical isolates 
to clarify the role of this proteins in phathogenesis.
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